StreetInsider.com News Articles

Form 3 MDxHealth SA For: May 18 Filed by: OConnell Brendan

Thu, 28 May 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260528/26567169.html

Form 3 MDxHealth SA For: May 18 Filed by: OConnell Brendan

Thu, 28 May 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260528/26567169.html

William Blair Downgrades MDxHealth SA (MDXH) to Market Perform

Thu, 14 May 2026 09:27:07 -0400

William Blair analyst Andrew Brackmann downgraded MDxHealth SA (NASDAQ: MDXH) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on MDxHealth SA click here. For more ratings news on MDxHealth SA click here.

Shares of MDxHealth SA closed at $1.95 yesterday.

MDxHealth SA (MDXH) PT Lowered to $3 at Craig-Hallum

Thu, 14 May 2026 09:17:29 -0400

Craig-Hallum analyst John Wilkin lowered the price target on MDxHealth SA (NASDAQ: MDXH) to $3.00 (from $8.00) while maintaining a Buy rating.

MDxHealth SA (MDXH) PT Lowered at TD Cowen on 'Sales Miss & Guidance Cut'

Thu, 14 May 2026 09:02:48 -0400

(Updated - May 14, 2026 9:02 AM EDT)

TD Cowen analyst Dan Brennan lowered the price target on MDxHealth SA (NASDAQ: MDXH) to $1.50 (from $7.00) while maintaining a Buy rating.

The analyst commented: "Weak 1Q With Medicare Claims Issue, Sales Miss & Guidance Cut; 1Q was disappointing, with pro forma sales ~9% below cons and MDXH announced its discontinuing its Resolve UTI test (~16% of sales; growth > corp. avg.) after a notice from its local Medicare MAC, seeking to recoup $10.4M in past payments related to a review of historical Resolve claims (MDx strongly disagrees & is contesting the decision).

MDxHealth SA (MDXH) PT Lowered at TD Cowen on 'Sales Miss & Guidance Cut'

Thu, 14 May 2026 09:02:48 -0400

(Updated - May 14, 2026 9:02 AM EDT)

TD Cowen analyst Dan Brennan lowered the price target on MDxHealth SA (NASDAQ: MDXH) to $1.50 (from $7.00) while maintaining a Buy rating.

MDxHealth SA (MDXH) PT Lowered to $5 at Lake Street

Thu, 14 May 2026 08:55:57 -0400

Lake Street analyst Thomas Flaten lowered the price target on MDxHealth SA (NASDAQ: MDXH) to $5.00 (from $9.00) while maintaining a Buy rating.

Form 6-K MDxHealth SA For: May 13

Wed, 13 May 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260513/26486455.html

Form 6-K MDxHealth SA For: May 13

Wed, 13 May 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260513/26486455.html

MDxHealth SA (MDXH) Misses Q1 EPS by 2c

Wed, 13 May 2026 16:03:20 -0400

MDxHealth SA (NASDAQ: MDXH) reported Q1 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $31.12 million.

For earnings history and earnings-related data on MDxHealth SA (MDXH) click here.

Mdxhealth Reports Q1-2026 Results

Wed, 13 May 2026 16:00:00 -0400

Mdxhealth Reports Q1-2026 Results